Skip to main content

Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin

Objective

To evaluate serial anti-Xa 'peak' levels drawn 2 or 4 hours post LMWH prophylaxis in 13 consecutive ICU patients with a range of renal function.

Setting

Multidisciplinary, closed, university-affiliated 15-bed medical–surgical ICU.

Method

We measured anti-Xa blood levels either 2 or 4 hours post dalteparin administration each day until death or discharge. We calculated creatinine clearance daily using the Cockroft-Gault formula. We graphed these peak anti-Xa levels against calculated creatinine clearance values, and examined their relation to bleeding events.

Results

We performed 287 anti-Xa levels on these ICU patients, and found that peak anti-Xa levels were consistently less than 0.5 U/ml. We did not demonstrate a relationship between the timing of the peak anti-Xa levels, and a) the value of the peak anti-Xa levels, b) the patients' calculated creatinine clearance, or c) bleeding events.

Conclusions

Anti-Xa levels drawn 2 or 4 hours post subcutaneous injection of 5000 U dalteparin in this sample of patients were consistently less than 0.5 U/ml, but did not vary significantly with renal function.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

McDonald, E., Landry, F., Rabbat, C. et al. Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin. Crit Care 7, P112 (2003). https://doi.org/10.1186/cc2001

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc2001

Keywords

  • Molecular Weight
  • Creatinine
  • Renal Function
  • Heparin
  • Emergency Medicine